[PL]The challenge of pharmaceutical science to create a sustainable future
○Itsuko Ishii1(1. Div. Pharm., Chiba Univ. Hosp.)
Search Criteria
Keywords :
Year :
2020 - 2026
Search across all events. Up to 10,000 search results will be displayed.
-
Search Criteria
| Keywords : | |
|---|---|
| Year : | 2020 - 2026 |
Search across all events. Up to 10,000 search results will be displayed.
-
Search Results(10,000+)
Due to the large number of search results, only up to 10,000 are displayed. If you cannot find the results you need, please refine your search by specifying additional conditions.
[SL01]PHOTOPHARMACOLOGY
Controlling Biological Activity with Light
○Bernard L. Feringa1(1. University of Groningen, Stratingh Institute for Chemistry, Faculty of Science and Engineering)
[SL02]Dynamics of the function and regulation of the endoplasmic reticulum
○Kazutoshi Mori1(1. Kyoto University Institute for Advanced Study)
[SL03]The Future of AI/DX Driven Drug Discovery
○Yasushi Okuno1(1. Kyoto Univ.)
[SL04]Development of novel therapeutic drugs for Alzheimer's disease based on elucidation of risk factor mechanisms
○Naoyuki Sato1(1. National Center for Geriatrics and Gerontology)
[SL05]Identification of asymmetric components of vertebrate flagella using cryo-electron tomography
Hiroshi Yamaguchi1, ○Masahide Kikkawa1(1. The Univ. of Tokyo, Grad. Schl. Of Med)
[SL06]Challenges in the development and implementation of domestic genome editing technology
○Takashi Yamamoto1(1. Hiroshima Univ., Genome Editing Center)
[SL07]Structure-guided drug development based on structural physiology
○Yoshinori Fujiyoshi1(1. IIR, Science Tokyo)
[SL08]Inorganic and Biologically Derived Nanotechnology for Biomedical Applications
○David T. Leong1(1. Department of Chemical and Biomolecular Engineering, National University of Singapore)
[SL09]Elucidating membrane protein functions by nuclear magnetic resonance
○Ichio Shimada1(1. Riken)
[SL10]Rewriting protein modifications
○Christina M. Woo1(1. Department of Chemistry & Chemical Biology, Harvard University)
[SL11]Immunological Research and Clinical Applications: Insights into Neuro-Immune-Metabolic Interactions
○Atsushi Kumanogoh1, Yoshimitsu Nakanishi1, Mayuko Izumi1(1. Graduate School of Medicine, The University of Osaka)
[SL12]Regnase-1: a master regulator connecting inflammatory, immune, and metabolic pathways
○Shizuo Akira1(1. IFReC, The University of Osaka)
[SL13]Immuno-gerotherapeutics targeting senescent cells for age-associated disease
○Tohru Minamino1(1. Juntendo Univ. Grad. Sch. of Med.)
[SL14]The Role of BRIN's in Strengthening Indonesia's National Health Research Ecosystem
○NiLuh Putu Indi Dharmayanti1(1. Research Organization for Health, BRIN, Indonesia)
[SL15]Toward Building an Ecosystem to Cultivate Pharmaceutical Professionals for the Future
○Kazuhiko Mori1(1. TOYAMA Pharmaceutical Consortium)
[SL16]Risk assessment in food safety
○Sobue Tomotaka1(1. Food safety commission of Japan)
[AL01]Integrated structural biology of glycoproteins oriented toward biopharmaceutical applications
○Koichi Kato1,2(1. NINS ExCELLS, 2. Grad. Sch. Pharm. Sci., Nagoya City Univ.)
[AL02]Metabolic activations and pharmacokinetics of drugs using data-driven modeling
○Hiroshi Yamazaki1(1. Showa Pharma Univ)
[AL03]Structural elucidation of ligand recognition and activation control mechanisms in innate immune sensors
○Toshiyuki Simizu1(1. Grad. School Pharm. Sci., The Univ of Tokyo)
[AL04]Medicinal chemistry and chemical biology based on peptides and peptidomimetics
○Hirokazu Tamamura1(1. Lab. Biomat. Bioeng., IIR, Science Tokyo)
[AL05]Contributions to research for pharmaceutical health science through the initiation and development of vascular toxicology
○Toshiyuki Kaji1(1. Tokyo Univ. of Sci.)
[AL06]Innovative Separation Analysis and Regenerative Medicine using Functional Polymer
○Kenichi Nagase1(1. Grad Sch Biomed Health Sci)
[AL07]Molecular pharmacological research on TRP channels in central nervous system disorders.
○Hisashi Shirakawa1(1. Grad. Sch. Pharm., Kyoto Univ.)
[AL08]Development of mitochondria-activated cells to accelerate cell transplantation therapy
○Yuma Yamada1(1. Fac. Pharm. Sci., Hokkaido Univ.)
[AL09]Precisive molecular constructions utilizing hydrogen, water and iron catalysts
○Yoshinari Sawama1(1. Grad. Sch. Pharm. Sci, The Univ. of Osaka)
[AL10]Secondary structure-driven peptide drug discovery
○Yosuke Demizu1(1. NIHS)
[AL11]Formation of cyclic amino acids from unprotected amino acids and multi-elongations to both termini and side chains of cyclic peptides
○Tomohiro Hattori1(1. Chubu Univ.)
[AL12]Development of diverse drug delivery systems to overcome biological barriers and for the treatment of brain diseases
○Tatsuya Fukuta1(1. Sch. Pharm. Sci., Wakaya Med. Univ.)
[AL13]Hippocampal representation of "the mortal” and “the marital"
○Nobuyoshi Matsumoto1,2(1. Grad Sch Pharmaceut Sci, Univ Tokyo, 2. The Institute for AI and Beyond, Univ Tokyo)
[AL14]Development of Novel Medicinal Chemistry Frameworks Based on Chemical Intervention in Biopolymers Homeostasis
○Shusuke Tomoshige1(1. Grad. Sch. Life Sci., Tohoku Univ.)
[AL15]Biosynthesis of secondary metabolites produced by pathogenic fungi
○Shinji Kishimoto1(1. Univ. Shizuoka)
[AL16]Development of novel functional supramolecular gels via rational design of small molecules: Pharmaceutical applications and elucidation of formation mechanism
○Shinya Kimura1(1. Meiji Pharm. Univ.)
[AL17]Medicinal chemistry on nucleic acid modalities spanning broad molecular hierarchies
○Noriko Saito-Tarashima1(1. Grad. School of Pharm. Sci., Tokushima Univ.)
[AL18]Design and development of intracellular delivery platforms for macromolecular therapeutics
○Yoshimasa Kawaguchi1(1. Inst. Chem. Res., Kyoto Univ.)
[AL19]Development of transmucosal drug delivery systems targeting the oral cavity and brain
○Akiko Tanaka1(1. Kobe Pharm. Univ.)
[AL20]Contributions to the Promotion of the 6-Year Pharmacy Education Reform and International Dissemination
○Koichiro Ozawa1(1. Fac. Pharm., Yasuda Women’s University.)
[AL21]Contribution to Promoting Self-Medication and the Widespread Use of Over-the-Counter (OTC) Medicines Through the Education of Pharmacy Students and Pharmacists~Role as a gateway of local medical care~
○Mayumi Mochizuki1(1. Professor Emeritus, Keio Univ.)
[AL22]Invention of a SARS-CoV-2 RNA vaccine using DS-LNP-mRNA technology
○Nao Jonai1, Natsuki Tanaka2, Takako Niwa3, Takashi Suzuki4(1. Vaccine Research Laboratories, Daiichi Sankyo Co., LTD., 2. R&D Portfolio Planning Department, Daiichi Sankyo Co., LTD., 3. Modality Research Laboratories I, Daiichi Sankyo Co., LTD., 4. Bioprocess Technology Research Laboratories II, Daiichi Sankyo Co., LTD.)
[AL23]Discovery of Brexpiprazole, a Serotonin-Dopamine Activity Modulator (SDAM)
Nobuaki Ito1, Hiroshi Yamashita2, Shin Miyamura3, ○Kenji Maeda4, Tetsuro Kikuchi5(1. Medicinal Chemistry, Otsuka Pharmaceutical, 2. IP, Otsuka Pharmaceutical, 3. Research Management, Otsuka Pharmaceutical, 4. MA, Otsuka Pharmaceutical, 5. Pharmaceutical Division, Otsuka Pharmaceutical)
[AL24]Optimization of infectious disease treatment through clinical practice-based personalized therapy and big data analysis
○Yuichi Muraki1(1. Kyoto Pharmaceutical University)
[IS01-1]Cyclopropanols as gateways to structurally diverse molecules
○Naohiko Yoshikai1(1. Grad. Sch. Pharm. Sci., Tohoku Univ.)
[IS01-2]Chemical biology based on natural products ~Notch inhibitor and microorganism-animal cells co-culture~
○Midori Arai1(1. Fac. Sci. Tech., Keio Univ.)
[IS01-3]Borane-catalyzed functionalization reactions of pyridines and amines
○Xiao-Chen Wang1(1. Col. Chem. Nankai Univ.)
[IS03-1]From tradition to innovation: green extractions and the BCG model in natural product development
○Pharkphoom Panichayupakaranant1(1. Pharm. Sci., Prince of Songkla Univ., Thailand)
[IS03-2]Hijacking nature's toolbox: cofactor targeting inhibitors of epigenetic enzymes
○Manfred Jung1(1. Inst. Pharm. Sci., Univ. Freiburg, Germany)
[IS03-3]Unlocking novel polyphenol therapeutics from Cannabis: from in silico insights to innovative formulations of cannflavins and stilbenes
○Neal M Davies1, Conor O'Croinin1, Raimar Löbenberg1, Michael R Doschak1(1. Univ. Alberta, Fac. Pharm. and Pharm. Sci., Canada)
[IS03-4]Engineering of biosynthetic enzymes to synthesizebioactive compounds
○Hiroyuki Morita1(1. INM, Univ. Toyama, Japan)
[IS03-5]Investigation of the anti-lipid droplet accumulation and anti-inflammatory active constituents from Formosan plants
○Hsun-Shuo Chang1(1. Sch. Pharm., Kaohsiung Med. Univ., Taiwan)
[IS02-1]Medication safety of oral anticancer therapy
○Ulrich Jaehde1,2(1. Dept. Clin. Pharm., Pharm. Inst, Univ. Bonn, Germany, 2. President, German Pharmaceutical Society)
10,000 results ( 1 - 50 )
- 1
- ...